Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

Dow Jones Drops After Weak Manufacturing Data; Goldman Sachs Slides On Earnings Miss

The Dow Jones dropped Tuesday ahead of more key inflation data due out Wednesday. Goldman Sachs fell on an earnings miss.

Investors Business Daily

Obesity treatments catch drugmakers’ eyes as sales seen soaring

Three years ago, drugmakers and laboratories around the world responded to the pandemic with Covid-19 vaccines. Now that the urgency has faded, they’re collectively turning attention to an older pandemic: obesity.

Tribune News Service

Genetics, Alzheimer's And AI — Why 2023 Could Be The Year For Biotech Stocks

If there's one biotech area to watch in 2023, it's genetic medicine, like CRISPR. But other trends also point to a big year for biotech stocks.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

'Dogs Of The Dow' Stocks Just Paid Off; Here Are The Top 10 For 2023

Owning the "Dogs Of The Dow" stocks paid off in 2022. And they could be even more lucrative this year.

Investors Business Daily

IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock

Eli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's and obesity, driving LLY stock near highs.

Investors Business Daily

Dow Jones Reverses Lower Amid Economic Data; Tesla Dives On Deliveries Miss

The Dow Jones Industrial Average reversed lower Tuesday amid economic data. Tesla stock dived after reporting record deliveries that missed estimates.

Investors Business Daily

Dow Jones Falls 275 Points In Final Trading Day

The Dow Jones fell 275 points Friday in the final session of 2022. Tesla stock is set to finish with its worst yearly performance on record.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Rallies 300 Points After Jobless Claims; Tesla Stock Surges On Reiterated Buy Rating

The Dow Jones rallied Thursday after first-time jobless claims. Tesla stock raced higher on a reiterated overweight rating.

Investors Business Daily

The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock

Investors are closely watching two Eli Lilly battles that will unfold in 2023 as LLY stock continues a fevered streak, tacking on new highs.

Investors Business Daily

Dow Jones Rises After Weak Housing Data; Tesla Stock Hits New Low Amid Historic Plunge

The Dow Jones rose Wednesday after key economic data. Tesla stock hit a new low, threatening to add to December's historic plunge.

Investors Business Daily

Dow Jones Falls After Housing Data As Apple Hits New Low; Tesla Plunges On Reduced Production Schedule In China

The Dow Jones Industrial Average turned lower after economic data. Tesla dived on a report that the EV giant will run a reduced production schedule at its Shanghai plant in January.

Investors Business Daily

Dow Jones Falls On Inflation Data; Tesla Stock Hits New Low Amid Elon Musk Comments

The Dow Jones Industrial Average dropped Friday on key inflation data. Tesla stock hit a new low amid Elon Musk's comments on not selling shares.

Investors Business Daily

Dow Jones Dives After GDP, Jobless Data; CarMax Plunges On 'Vehicle Affordability Issues'

The Dow Jones dived more than 400 points Thursday after first-time jobless claims and GDP. CarMax plunged on "vehicle affordability issues."

Investors Business Daily

Dow Jones Rallies After Economic Data; Nike Surges 15% On Earnings; Tesla Hits New Low

The Dow Jones rallied 375 points Wednesday after consumer and housing data, as Nike stock surged 15% on strong earnings results.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

Investors Business Daily

How A Bullish Risk Reversal Option Trade Works On Amgen Stock

Risk reversal option trades combine a short out-of-the-money put and a long out-of-the-money call. Here's how it works.

Investors Business Daily

The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen

Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance.

Investors Business Daily

Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Closes Higher Ahead Of Fed Meeting On Expected Lower Inflation; Energy, Tech Stocks Advance

Stock market gains ahead of Fed meeting on expected lower inflation. Database leader Box gains on upgrade.

Chicago Sun-Times

Amgen to buy Horizon Therapeutics in $26.4B deal

Horizon Therapeutics, whose U.S. headquarters is in Deerfield, is a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases.

Investors Business Daily

Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal

Amgen announced a $28.3 billion plan to acquire Horizon Therapeutics on Monday, leading HZNP stock to soar higher.

Investors Business Daily

Dow Jones Rises Ahead Of Inflation Data, Fed Meeting; Amgen To Acquire Horizon Therapeutics

The Dow Jones Industrial Average rose Monday morning, as investors prepared for more inflation data and the Fed meeting this week.

The Independent UK

Amgen to buy Horizon Therapeutics in $26.4B deal

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion

Investors Business Daily

How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Investors Business Daily

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.